Machina Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Machina Capital’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$703K	Buy	+2,335	New	+$704K	0.11%	229
2024 Q3	–	Sell	-4,266	Closed	-$1.04M	–	280
2024 Q2	$1.04M	Buy	+4,266	New	+$673K	0.47%	78
2023 Q3	–	Sell	-1,324	Closed	-$251K	–	259
2023 Q2	$251K	Buy	+1,324	New	+$262K	0.14%	227
2022 Q4	–	Sell	-1,717	Closed	-$344K	–	140
2022 Q3	$344K	Buy	+1,717	New	+$327K	0.73%	57

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Machina Capital's ALNY Position: Q2 2026 in Review

Machina Capital opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 2,335 shares worth $703K. The stake represents 0.11% of the portfolio and ranks #229 among its holdings. This is a return to the name: Machina Capital previously reported a position in ALNY as recently as Q2 2024.

Machina Capital first reported a position in ALNY in Q3 2022 and has held it in 4 quarters since. The position peaked at $1.04M in Q2 2024. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Machina Capital held 2,335 shares of Alnylam Pharmaceuticals worth $703K as of Q2 2026.
Alnylam Pharmaceuticals was a new Machina Capital position in Q2 2026.
Alnylam Pharmaceuticals made up 0.11% of Machina Capital's portfolio in Q2 2026, its #229 holding.
Machina Capital first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 4 quarters since.
Machina Capital's Alnylam Pharmaceuticals position peaked at $1.04M in Q2 2024.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.